(Q36740188)

16 August 2017

Standardization of nomenclature and causality assessment in drug-induced liver injury: summary of a clinical research workshop (English)

1 reference

16 August 2017

0 references

Robert J Fontana

1

1 reference

16 August 2017

Leonard B Seeff

2

1 reference

16 August 2017

Raúl J Andrade

3

1 reference

16 August 2017

Einar Björnsson

4

1 reference

16 August 2017

Christopher P Day

5

1 reference

16 August 2017

Jose Serrano

6

1 reference

16 August 2017

Jay H Hoofnagle

7

1 reference

16 August 2017

language of work or name

English

0 references

publication date

1 August 2010

1 reference

16 August 2017

1 reference

16 August 2017

52

1 reference

16 August 2017

730-742

1 reference

16 August 2017

2

1 reference

The pathology of drug-induced liver injury

16 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3616501

Intravenous N-acetylcysteine improves transplant-free survival in early stage non-acetaminophen acute liver failure

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3616501

HLA-B*5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillin

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3616501

Drug-induced liver injury following positive drug rechallenge

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3616501

Drug-Induced Liver Injury Network (DILIN) prospective study: rationale, design and conduct

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3616501

Causes, clinical features, and outcomes from a prospective study of drug-induced liver injury in the United States

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3616501

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3616501

Reliability of the Roussel Uclaf Causality Assessment Method for assessing causality in drug-induced liver injury

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3616501

Abacavir hypersensitivity reaction: an update

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3616501

Increased susceptibility for intrahepatic cholestasis of pregnancy and contraceptive-induced cholestasis in carriers of the 1331T>C polymorphism in the bile salt export pump

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3616501

Etiology of new-onset jaundice: how often is it caused by idiosyncratic drug-induced liver injury in the United States?

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3616501

Drug-induced liver injury: an analysis of 461 incidences submitted to the Spanish registry over a 10-year period

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3616501

Acute and clinically relevant drug-induced liver injury: a population based case-control study.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3616501

Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3616501

Incidence of drug-induced hepatic injuries: a French population-based study

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3616501

Hepatotoxicity associated with antiretroviral therapy in adults infected with human immunodeficiency virus and the role of hepatitis C or B virus infection

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3616501

The natural history of histologically proved drug induced liver disease

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3616501

Hypersensitivity syndrome to antiepileptic drugs: a review including new anticonvulsants.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3616501

Risk factors for hepatotoxicity from antituberculosis drugs: a case-control study

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3616501

Causality assessment of adverse reactions to drugs--I. A novel method based on the conclusions of international consensus meetings: application to drug-induced liver injuries

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3616501

A method for estimating the probability of adverse drug reactions

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3616501

Reye's syndrome: current concepts

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3616501

Valproic acid hepatic fatalities: a retrospective review

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3616501

Methotrexate and histologic hepatic abnormalities: a meta-analysis

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3616501

Adverse Reactions with Methyldopa-a Decade's Reports

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3616501

Phenotypic characterization of idiosyncratic drug-induced liver injury: the influence of age and sex.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3616501

Drug-induced liver injury in Japan: An analysis of 1676 cases between 1997 and 2006.

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3616501

The long-term follow-up after idiosyncratic drug-induced liver injury with jaundice

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3616501

Evaluation of naranjo adverse drug reactions probability scale in causality assessment of drug-induced liver injury.

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3616501

Reversible valproate hepatotoxicity due to mutations in mitochondrial DNA polymerase gamma (POLG1).

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3616501

Drug-induced liver injury: summary of a single topic clinical research conference

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3616501

Patients with elevated baseline liver enzymes do not have higher frequency of hepatotoxicity from lovastatin than those with normal baseline liver enzymes.

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3616501

The burden of acute nonfulminant drug-induced hepatitis in a United States tertiary referral center [corrected].

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3616501

[Clinical characteristics of acute toxic liver injury].

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3616501

Assessment of 287 Japanese cases of drug induced liver injury by the diagnostic scale of the International Consensus Meeting

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3616501

Clinical diagnostic scale: a useful tool in the evaluation of suspected hepatotoxic adverse drug reactions.

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3616501

Comparing reporting rates of adverse events between drugs with adjustment for year of marketing and secular trends in total reporting.

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3616501

Imputation of the unexpected or toxic effects of drugs. Actualization of the method used in France

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3616501

Causality assessment in drug-induced liver injury using a structured expert opinion process: comparison to the Roussel-Uclaf causality assessment method

5 September 2018

1 reference

Crossref

https://api.crossref.org/works/10.1002%2FHEP.23696

Antituberculosis drug-related liver dysfunction in chronic hepatitis B infection

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1002%2FHEP.23696

Causality assessment of adverse reactions to drugs--II. An original model for validation of drug causality assessment methods: case reports with positive rechallenge

21 January 2018

1 reference

12 December 2020

Chronic active hepatitis and severe hepatic necrosis associated with nitrofurantoin

1 reference

12 December 2020

Drug-induced liver injury at an Asian center: a prospective study

1 reference

12 December 2020

Hy's law: predicting serious hepatotoxicity

1 reference

12 December 2020

Drug-induced liver injury in a Swedish University hospital out-patient hepatology clinic

1 reference

12 December 2020

Diagnosis of drug-induced liver injury in Japanese patients by criteria of Consensus Meetings in Europe

1 reference

12 December 2020

Comparison of two clinical scales for causality assessment in hepatotoxicity

1 reference

12 December 2020

Agreement of expert judgment in causality assessment of adverse drug reactions

1 reference

12 December 2020

Development and validation of a clinical scale for the diagnosis of drug-induced hepatitis

1 reference

12 December 2020

Drug-Induced Liver Injury: An Analysis of 461 Incidences Submitted to the Spanish Registry Over a 10-Year Period

1 reference

Crossref

https://api.crossref.org/works/10.1002%2FHEP.23696

7 January 2021

inferred from DOI database lookup

Identifiers

DOI

10.1002/HEP.23696

1 reference

16 August 2017

1 reference

16 August 2017

1 reference